Determining the effector response to cell death
Publication type: Journal Article
Publication date: 2020-11-13
scimago Q1
wos Q1
SJR: 17.458
CiteScore: 84.7
Impact factor: 60.9
ISSN: 14741733, 14741741
PubMed ID:
33188303
Energy Engineering and Power Technology
Fuel Technology
Abstract
Cell death occurs when a pathogen invades a host organism or the organism is subjected to sterile injury. Thus, cell death is often closely associated with the induction of an immune response. Furthermore, cell death can occur as a consequence of the immune response and precedes the tissue renewal and repair responses that are initiated by innate immune cells during resolution of an immune response. Beyond immunity, cell death is required for development, morphogenesis and homeostasis. How can such a ubiquitous event as cell death trigger such a wide range of context-specific effector responses? Dying cells are sensed by innate immune cells using specialized receptors and phagocytosed through a process termed efferocytosis. Here, we outline a general principle whereby signals within the dead cell as well as the environment are integrated by specific efferocytes to define the appropriate effector response. Cell death recognition can result in a multitude of distinct effector responses. Here, the authors discuss a framework for determining the specific effector response to cell death that relies on its recognition, contextual environmental signals and the identity of the efferocyte.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
|
|
|
Frontiers in Immunology
3 publications, 5.45%
|
|
|
Methods in Cell Biology
3 publications, 5.45%
|
|
|
Frontiers in Cell and Developmental Biology
2 publications, 3.64%
|
|
|
iScience
2 publications, 3.64%
|
|
|
Cell Metabolism
2 publications, 3.64%
|
|
|
eLife
2 publications, 3.64%
|
|
|
Biochemical Society Transactions
1 publication, 1.82%
|
|
|
Genes
1 publication, 1.82%
|
|
|
Cells
1 publication, 1.82%
|
|
|
Nature Immunology
1 publication, 1.82%
|
|
|
Signal Transduction and Targeted Therapy
1 publication, 1.82%
|
|
|
Immunity
1 publication, 1.82%
|
|
|
Cell Reports
1 publication, 1.82%
|
|
|
Cell
1 publication, 1.82%
|
|
|
Frontiers in Oncology
1 publication, 1.82%
|
|
|
Cell Death and Differentiation
1 publication, 1.82%
|
|
|
Current Opinion in Immunology
1 publication, 1.82%
|
|
|
Nanotoxicology
1 publication, 1.82%
|
|
|
Science Translational Medicine
1 publication, 1.82%
|
|
|
Proceedings of the National Academy of Sciences of the United States of America
1 publication, 1.82%
|
|
|
Journal of Pathology
1 publication, 1.82%
|
|
|
Journal of Translational Medicine
1 publication, 1.82%
|
|
|
PLoS ONE
1 publication, 1.82%
|
|
|
Journal of Cancer Research and Clinical Oncology
1 publication, 1.82%
|
|
|
Immunological Reviews
1 publication, 1.82%
|
|
|
Journal for ImmunoTherapy of Cancer
1 publication, 1.82%
|
|
|
Seminars in Cell and Developmental Biology
1 publication, 1.82%
|
|
|
Molecular Biotechnology
1 publication, 1.82%
|
|
|
Journal of Neuro-Oncology
1 publication, 1.82%
|
|
|
1
2
3
|
Publishers
|
2
4
6
8
10
12
14
16
|
|
|
Elsevier
15 publications, 27.27%
|
|
|
Springer Nature
11 publications, 20%
|
|
|
Frontiers Media S.A.
6 publications, 10.91%
|
|
|
Wiley
5 publications, 9.09%
|
|
|
MDPI
3 publications, 5.45%
|
|
|
Cold Spring Harbor Laboratory
3 publications, 5.45%
|
|
|
eLife Sciences Publications
2 publications, 3.64%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
2 publications, 3.64%
|
|
|
Portland Press
1 publication, 1.82%
|
|
|
Taylor & Francis
1 publication, 1.82%
|
|
|
American Association for the Advancement of Science (AAAS)
1 publication, 1.82%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
1 publication, 1.82%
|
|
|
Public Library of Science (PLoS)
1 publication, 1.82%
|
|
|
BMJ
1 publication, 1.82%
|
|
|
Oxford University Press
1 publication, 1.82%
|
|
|
American Chemical Society (ACS)
1 publication, 1.82%
|
|
|
2
4
6
8
10
12
14
16
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
55
Total citations:
55
Citations from 2024:
17
(30.91%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Rothlin C. V. et al. Determining the effector response to cell death // Nature Reviews Immunology. 2020. Vol. 21. No. 5. pp. 292-304.
GOST all authors (up to 50)
Copy
Rothlin C. V., Hille T. D., Ghosh S. Determining the effector response to cell death // Nature Reviews Immunology. 2020. Vol. 21. No. 5. pp. 292-304.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1038/s41577-020-00456-0
UR - https://doi.org/10.1038/s41577-020-00456-0
TI - Determining the effector response to cell death
T2 - Nature Reviews Immunology
AU - Rothlin, Carla V
AU - Hille, Thomas D
AU - Ghosh, Sourav
PY - 2020
DA - 2020/11/13
PB - Springer Nature
SP - 292-304
IS - 5
VL - 21
PMID - 33188303
SN - 1474-1733
SN - 1474-1741
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2020_Rothlin,
author = {Carla V Rothlin and Thomas D Hille and Sourav Ghosh},
title = {Determining the effector response to cell death},
journal = {Nature Reviews Immunology},
year = {2020},
volume = {21},
publisher = {Springer Nature},
month = {nov},
url = {https://doi.org/10.1038/s41577-020-00456-0},
number = {5},
pages = {292--304},
doi = {10.1038/s41577-020-00456-0}
}
Cite this
MLA
Copy
Rothlin, Carla V., et al. “Determining the effector response to cell death.” Nature Reviews Immunology, vol. 21, no. 5, Nov. 2020, pp. 292-304. https://doi.org/10.1038/s41577-020-00456-0.